NDC 63083-2027

Headache Drops 2027

Headache Drops

Headache Drops 2027 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Professional Complementary Health Formulas. The primary component is Amaryllis Belladonna Whole; Coffea Arabica Seed, Roasted; Gelsemium Sempervirens Root; Lachesis Muta Venom; Lycopodium Clavatum Spore; Nitroglycerin; Onion; Pulsatilla Montana Whole; Sodium Chloride; Spigelia Anthelmia Whole; Strychnos Nux-vomica Seed.

Product ID63083-2027_a580995b-4ac7-442c-95f3-0af3b9160fe8
NDC63083-2027
Product TypeHuman Otc Drug
Proprietary NameHeadache Drops 2027
Generic NameHeadache Drops
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1984-08-15
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameProfessional Complementary Health Formulas
Substance NameAMARYLLIS BELLADONNA WHOLE; COFFEA ARABICA SEED, ROASTED; GELSEMIUM SEMPERVIRENS ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; ONION; PULSATILLA MONTANA WHOLE; SODIUM CHLORIDE; SPIGELIA ANTHELMIA WHOLE; STRYCHNOS NUX-VOMICA SEED
Active Ingredient Strength4 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
Pharm ClassesAllergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE], Vegetable Proteins [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63083-2027-2

59 mL in 1 BOTTLE, DROPPER (63083-2027-2)
Marketing Start Date1985-08-15
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.